﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Hamadan University of Medical Sciences</PublisherName>
      <JournalTitle>Avicenna Journal of Pharmaceutical Research</JournalTitle>
      <Issn>2717-1884</Issn>
      <Volume>1</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2020</Year>
        <Month>07</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Preparation, Box-Behnken Statistical Optimization, and In Vitro Characterization of a Self-nanoemulsifying Drug Delivery System for the Oral Delivery of Budesonide as a Poorly Soluble Drug</ArticleTitle>
    <FirstPage>24</FirstPage>
    <LastPage>32</LastPage>
    <ELocationID EIdType="doi">10.34172/ajpr.2020.05</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Sahar</FirstName>
        <LastName>Khoshyari</LastName>
      </Author>
      <Author>
        <FirstName>Reza</FirstName>
        <LastName>Mahjub</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/ajpr.2020.05</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2020</Year>
        <Month>03</Month>
        <Day>01</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2020</Year>
        <Month>04</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <Abstract>Background: Self-nanoemulsifying drug delivery systems (SNEDDS) can be used to improve the oral bioavailability of lipophilic drugs. The aim of this study was the preparation and characterization of a SNEDDS for the oral delivery of budesonide as a poorly soluble drug. Methods: To prepare SNEDDS, budesonide (20 mg) was dissolved in the mixture of liquid paraffin, Tween 80, and propylene glycol, followed by using the Box-Behnken response surface methodology for statistical optimization. The prepared mixtures were then diluted in the simulated intestinal fluid (SIF) and their physico-chemical characteristics were studied as well. Then, SNEDDS were morphologically evaluated using transmission electron microscopy (TEM). Finally, the in vitro release profile of budesonide from nano-droplets was determined in the SIF. Results: Based on the results, the size, polydispersity index, zeta potential, and entrapment efficiency of statistically optimized SNEEDS were reported as 146±37 nm, 0.211±0.06, +3.6±0.84 mV, and 94.3±6.58%, respectively. In addition, TEM images revealed spherical nano-droplets. Further, the release profile of budesonide from nano-droplets exhibited 33.81±1.67% of drug release in SIF during 360 minutes of incubation at 37° C, indicating sustained drug release. Conclusion: The obtained data demonstrated that SNEDDS could be regarded as a good candidate for oral delivery of budesonide as a poorly water-soluble drug representing a high first-pass metabolism. </Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Budesonide</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Poorly water-soluble drugs</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Self-nanoemulsifying drug delivery system</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Oral delivery</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Lymphatic absorption</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Statistical optimization</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>